Darwin Global Management, Ltd.
CIK
1839209
Location
ST. HELIER, Y9
Portfolio Value
Mid
$3,871,688,327
Diversification
Highly concentrated
Filing Date
Global Rank
#1,059
/ 8,794
▼ 184
· as of Jun 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-0.6%
Period ended 3 months ago
Filed Aug 14, 2026 · 52d
21 quarters · since Dec 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
5 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
51.4%
−16.8 pts
Top 5
100.0%
+0.0 pts
Top 10
100.0%
0.0 pts
HHI
3,301
Highly concentrated−1,646
Portfolio Trend
21 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $3,871,688,327 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
3 positions
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 17,357 | $1,456,599 | |
| No positions match the current search. | ||||
5 tracked positions ·
$3,871,688,327 total
· filing declares
5 positions · $3,760,253,505
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 10,629,822 | $1,990,753,064 | 51.42% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 6,431,163 | $685,690,599 | 17.71% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 3,621,583 | $482,612,150 | 12.47% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Added | 3,077,219 | $473,845,567 | 12.24% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 6,747,300 | $238,786,947 | 6.17% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.